Type 1 diabetes

Hypo‐ and hyperglycaemia following pancreas transplantation for people with type 1 diabetes

Diabet MedPublished Observational study

Authors' conclusion

Recipients with post-transplantation hypoglycaemia were more likely to be women and of low body weight, which may be due to disordered eating with restricted calorie or carbohydrate intake. Recipients with post-transplantation hyperglycaemia had features of insulin resistance and type 2 diabetes with increased weight and men predominance. Glycaemic disturbance was not associated with graft failure

Study context

Population
People with T1D with a functioning pancreas transplant and glucose tolerance test (GTT) data, University Hospital Wales, January 2013 to April 2019
Participants
96 people
Exposure
Hypoglycaemia vs hyperglycaemia vs normoglycaemia after pancreas transplantation
Outcome
Rates of glycaemic disturbance
Methodological detailsroutinely collected data, single-centre
  • Routinely collected data
  • Single-centre

Main finding

As reported in the abstract

Glycaemic disturbance
Developed glycaemic disturbance
30%

Observational data: associations, not effects.

Further findings

Mean, kg/m²

OutcomeHypoglycaemiaHyperglycaemiaNormoglycaemiaDifference (kg/m²) (CI)P value
BMIHyperglycaemiavs Hypoglycaemia23.727.6— not stated in the abstract3.89 (0.77–7.0)P = 0.017

— not stated in the abstract

Graft failure — Hypoglycaemia vs Normoglycaemia · across all three groups

P = 0.70

OutcomeHypoglycaemiaHyperglycaemiaNormoglycaemiaP value
WomenHypoglycaemia vs Hyperglycaemia90%26%— not stated in the abstractP = 0.001

— not stated in the abstract

Graft failure

No increase in graft failure with glycaemic disturbance

Original publication

Hypo‐ and hyperglycaemia following pancreas transplantation for people with type 1 diabetes. Diabet Med. Published 7 April 2026. doi:10.1111/dme.70307

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.